TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
FrostPharma AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
122,923
|
93,128
|
57,593 |
Financial expenses |
1,987
|
1,415
|
1,392 |
Earnings before taxes |
9,407
|
18,918
|
-4,050 |
EBITDA |
12,292
|
20,786
|
-2,648 |
Total assets |
85,435
|
66,982
|
44,300 |
Current assets |
80,086
|
61,445
|
42,437 |
Current liabilities |
29,372
|
45,255
|
39,480 |
Equity capital |
28,314
|
20,878
|
4,821 |
- share capital |
40
|
39
|
42 |
Employees (average) |
15
|
10
|
8 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
33.1%
|
31.2%
|
10.9% |
Turnover per employee |
8,195
|
9,313
|
7,199 |
Profit as a percentage of turnover |
7.7%
|
20.3%
|
-7.0% |
Return on assets (ROA) |
13.3%
|
30.4%
|
-6.0% |
Current ratio |
272.7%
|
135.8%
|
107.5% |
Return on equity (ROE) |
33.2%
|
90.6%
|
-84.0% |
Change turnover |
29,316
|
40,200
|
-61,075 |
Change turnover % |
31%
|
76%
|
-51% |
Chg. No. of employees |
5
|
2
|
3 |
Chg. No. of employees % |
50%
|
25%
|
60% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.